BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33351722)

  • 1. In-silico identification of new inhibitors for Low-density lipoprotein receptor-related protein6 (LRP6).
    Enayatkhani M; Salimi M; Azadmanesh K; Teimoori-Toolabi L
    J Biomol Struct Dyn; 2022 Jul; 40(10):4440-4450. PubMed ID: 33351722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico studying of the whole protein structure and dynamics of Dickkopf family members showed that N-terminal domain of Dickkopf 2 in contrary to other Dickkopfs facilitates its interaction with low density lipoprotein receptor related protein 5/6.
    Sadeghi S; Poorebrahim M; Rahimi H; Karimipoor M; Azadmanesh K; Khorramizadeh MR; Teimoori-Toolabi L
    J Biomol Struct Dyn; 2019 Jul; 37(10):2564-2580. PubMed ID: 30035709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Inhibitor of DKK1/LRP6 Interactions Against the Alzheimer Disease: An Insilco Approach.
    Prajapat M; Singh H; Chaudhary G; Sarma P; Kaur G; Prakash Patel A; Medhi B
    Bioinform Biol Insights; 2023; 17():11779322231183762. PubMed ID: 37424708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel inhibitor of protein tyrosine phosphatases delta: structure-based pharmacophore modeling, virtual screening, flexible docking, molecular dynamics simulation, and post-molecular dynamics analysis.
    Ma YC; Yang B; Wang X; Zhou L; Li WY; Liu WS; Lu XH; Zheng ZH; Ma Y; Wang RL
    J Biomol Struct Dyn; 2020 Sep; 38(15):4432-4448. PubMed ID: 31625456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting homologous recombination (HR) repair mechanism for cancer treatment: discovery of new potential UCHL-3 inhibitors
    Alakhdar AA; Saleh AH; Arafa RK
    J Biomol Struct Dyn; 2022 Jan; 40(1):276-289. PubMed ID: 32851933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of potential drug for Alzheimer's disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation.
    Elangovan ND; Dhanabalan AK; Gunasekaran K; Kandimalla R; Sankarganesh D
    J Biomol Struct Dyn; 2021 Nov; 39(18):7065-7079. PubMed ID: 32779973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of Potential Breast Cancer Inhibitors through Molecular Docking and Molecular Dynamics Simulation.
    Pandi S; Kulanthaivel L; Subbaraj GK; Rajaram S; Subramanian S
    Biomed Res Int; 2022; 2022():3338549. PubMed ID: 35800218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential leukocyte antigen-related protein (PTP-LAR) inhibitors through 3D QSAR pharmacophore-based virtual screening and molecular dynamics simulation.
    Du S; Yang B; Wang X; Li WY; Lu XH; Zheng ZH; Ma Y; Wang RL
    J Biomol Struct Dyn; 2020 Sep; 38(14):4232-4245. PubMed ID: 31588870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics.
    Jade DD; Pandey R; Kumar R; Gupta D
    J Biomol Struct Dyn; 2022 Mar; 40(4):1702-1718. PubMed ID: 33034255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics and structure-based virtual screening and identification of natural compounds as Wnt signaling modulators: possible therapeutics for Alzheimer's disease.
    Manandhar S; Sankhe R; Priya K; Hari G; Kumar B H; Mehta CH; Nayak UY; Pai KSR
    Mol Divers; 2022 Oct; 26(5):2793-2811. PubMed ID: 35146638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular docking and molecular dynamics simulation approach to screen natural compounds for inhibition of
    Joshi T; Joshi T; Sharma P; Chandra S; Pande V
    J Biomol Struct Dyn; 2021 Feb; 39(3):823-840. PubMed ID: 31965918
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacophore based virtual screening, molecular docking and molecular dynamic simulation studies for finding ROS1 kinase inhibitors as potential drug molecules.
    Vanajothi R; Vedagiri H; Al-Ansari MM; Al-Humaid LA; Kumpati P
    J Biomol Struct Dyn; 2022 May; 40(8):3385-3399. PubMed ID: 33200682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High throughput screening, docking, and molecular dynamics studies to identify potential inhibitors of human calcium/calmodulin-dependent protein kinase IV.
    Beg A; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 May; 37(8):2179-2192. PubMed ID: 30044185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease.
    Shukla R; Singh TR
    J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation.
    Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z
    Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hammoudi NE; Benguerba Y; Attoui A; Hognon C; Lemaoui T; Sobhi W; Benaicha M; Badawi M; Monari A
    J Biomol Struct Dyn; 2022 Feb; 40(2):886-902. PubMed ID: 32948119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.